Javascript must be enabled to continue!
Neuroprotective Properties of Nutraceuticals in Regulating Neurodegenerative Dementia
View through CrossRef
Dementia is a syndrome marked by a loss of mental abilities due to damage to at least one cognitive function, resulting in poor brain performance that compromises daily life activities. The multiple pathologic pathways underlying neurodegenerative dementia include protein misfolding, oxidative stress, neuro-inflammation, mitochondrial dysfunction, and calcium overload. The syndrome is a major concern to the healthcare system since the therapeutic options are limited and it has multiple adverse effects. Such therapeutic options function particularly to alleviate signs and symptoms. Recently, nutraceuticals have attracted significant attention due to their neuroprotective properties against dementia. However, few studies have focused on the mechanisms mediating the neuroprotective effects of nutraceuticals or their effectiveness against dementia, particularly in regulating neurodegeneration. Therefore, this review underlines the nutraceuticals used against dementia that includes omega-3 (PUFA), flavonoid, curcumin, resveratrol, and vitamins and to establish their neuroprotective mechanisms. The review covers relevant clinical trials demonstrating the effectiveness of nutraceuticals in supporting the possible treatment in neurodegenerative dementia. In conclusion, it is evident that certain nutraceuticals showed neuroprotective properties such as antioxidant, anti-inflammatory and anti-amyloidogenic. The findings will be useful when employing nutraceuticals in the management or treatment of dementia.
UiTM Press, Universiti Teknologi MARA
Title: Neuroprotective Properties of Nutraceuticals in Regulating Neurodegenerative Dementia
Description:
Dementia is a syndrome marked by a loss of mental abilities due to damage to at least one cognitive function, resulting in poor brain performance that compromises daily life activities.
The multiple pathologic pathways underlying neurodegenerative dementia include protein misfolding, oxidative stress, neuro-inflammation, mitochondrial dysfunction, and calcium overload.
The syndrome is a major concern to the healthcare system since the therapeutic options are limited and it has multiple adverse effects.
Such therapeutic options function particularly to alleviate signs and symptoms.
Recently, nutraceuticals have attracted significant attention due to their neuroprotective properties against dementia.
However, few studies have focused on the mechanisms mediating the neuroprotective effects of nutraceuticals or their effectiveness against dementia, particularly in regulating neurodegeneration.
Therefore, this review underlines the nutraceuticals used against dementia that includes omega-3 (PUFA), flavonoid, curcumin, resveratrol, and vitamins and to establish their neuroprotective mechanisms.
The review covers relevant clinical trials demonstrating the effectiveness of nutraceuticals in supporting the possible treatment in neurodegenerative dementia.
In conclusion, it is evident that certain nutraceuticals showed neuroprotective properties such as antioxidant, anti-inflammatory and anti-amyloidogenic.
The findings will be useful when employing nutraceuticals in the management or treatment of dementia.
Related Results
Prescription Patterns of Anti-dementia and Psychotropic Drugs in People Living With Dementia in China
Prescription Patterns of Anti-dementia and Psychotropic Drugs in People Living With Dementia in China
Abstract
Pharmacotherapy of dementia is a critical intervention for managing symptoms of and slowing progression of dementia. However, evidence on prescribing patter...
ENGAGE-DEM : a model of engagement of people with dementia
ENGAGE-DEM : a model of engagement of people with dementia
Dementia is a neurodegenerative disease that affects cognition, producing a reduction in thinking, problem-solving, and mnemonic abilities, functioning, preventing affected people ...
MBI‐apathy, ApoEɛ2, and risk for Alzheimer disease dementia
MBI‐apathy, ApoEɛ2, and risk for Alzheimer disease dementia
AbstractBackgroundApathy, characterized by decreased interest, initiative, and emotional reactivity, is amongst the most common neuropsychiatric symptoms in dementia. However, apat...
Walking pace, handgrip strength, age, APOE genotypes, and new-onset dementia: the UK Biobank prospective cohort study
Walking pace, handgrip strength, age, APOE genotypes, and new-onset dementia: the UK Biobank prospective cohort study
Abstract
Background
The independent and additive associations of walking pace and grip strength on dementia risk and the potential modifying effects...
Prevalence, Factors Associated and Knowledge of Dementia in a Sample of Older Ugandans
Prevalence, Factors Associated and Knowledge of Dementia in a Sample of Older Ugandans
Abstract
Introduction:Dementia is on the rise due to increasing proportion of old people in Sub-Saharan Africa (SSA). Although dementia is misattributed to normal ageing or...
Rural general practitioner confidence in diagnosing and managing dementia: A two‐stage, mixed methods study of dementia‐specific training
Rural general practitioner confidence in diagnosing and managing dementia: A two‐stage, mixed methods study of dementia‐specific training
AbstractIntroductionDementias a prevalent chronic healthcare condition affecting 46 million people worldwide and projected to grow in the coming years. Australians living in rural ...
Journey to Diagnosis of Young-Onset Dementia: A Qualitative Study of People with Young-Onset Dementia and their Family Caregivers in Australia
Journey to Diagnosis of Young-Onset Dementia: A Qualitative Study of People with Young-Onset Dementia and their Family Caregivers in Australia
Objectives
This study aims to explore the journey to dementia diagnosis and reaction to the diagnosis from the perspective of people with young-onset dementia l...
Preeclampsia – A risk factor for dementia in women
Preeclampsia – A risk factor for dementia in women
Dear Editor,
Dementia is a broad term that includes a spectrum of diseases that affect our cognition, thinking ability, and performance of daily activities. According to the World ...

